Article ID Journal Published Year Pages File Type
8790181 Urologic Oncology: Seminars and Original Investigations 2018 4 Pages PDF
Abstract
Opponents of premanagement biopsy of small renal masses are not difficult to find. Many urologists contend that the benefits of biopsy do not outweigh the risks, arguing that the results do not influence management substantially and that the most useful information from renal mass biopsy can be attained with advanced imaging. In this article, we develop the counter arguments and demonstrate that renal mass biopsy should be implemented into the small renal mass management algorithm.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, ,